Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapeutic Duration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01106430
What this trial is testing

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Who this might be right for
Attention-Deficit/Hyperactivity Disorder
Shire 267
Not applicableStudy completedNCT04316156
What this trial is testing

Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled Trial

Who this might be right for
Breast Cancer
Samsung Medical Center 100
Post-approval studies (Phase 4)Study completedNCT06613919
What this trial is testing

Six-months Versus Nine-months ATT for Ocular TB

Who this might be right for
Tuberculosis (TB)UveitisRetinal Vasculitis+1 more
L.V. Prasad Eye Institute 58
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Not applicableActive Not RecruitingNCT06125795
What this trial is testing

Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain

Who this might be right for
Chronic Lymphocytic Leukemia
AbbVie 146
Post-approval studies (Phase 4)Not Yet RecruitingNCT06291012
What this trial is testing

Stopping Pneumonia Antibiotherapy Regimen Early

Who this might be right for
Community-acquired PneumoniaChild, Only
University Hospital, Montpellier 1,100
Not applicableEnded earlyNCT01447901
What this trial is testing

Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

Who this might be right for
Hyperlipoproteinemia Type I
Amsterdam Molecular Therapeutics 19
Not applicableStudy completedNCT01633918
What this trial is testing

FeetEnergy Approach to Increase Physical Activity and Reduce Screen Time in Adolescents

Who this might be right for
Physical ActivitySedentary BehaviorActive Commuting+2 more
UKK Institute 1,291
Post-approval studies (Phase 4)UnknownNCT02592980
What this trial is testing

Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients

Who this might be right for
Atrial Fibrillation
University of Sao Paulo General Hospital 300
Not applicableStudy completedNCT02080338
What this trial is testing

0.018 or 0.022 Bracket Slot System More Effective in Orthodontic Treatment?

Who this might be right for
Malocclusion
David Bearn 187
Not applicableStudy completedNCT03466008
What this trial is testing

Whole-Body Cryotherapy (WBC) as an Adjunct Treatment on Pain in Fibromyalgia Persons: Short Time Effect.

Who this might be right for
Fibromyalgia
Haute École Robert Schuman Libramont 24
Testing effectiveness (Phase 2)Study completedNCT00722735
What this trial is testing

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)

Who this might be right for
Urinary Tract Infections
MerLion Pharmaceuticals GmbH 36
Testing effectiveness (Phase 2)Ended earlyNCT00690118
What this trial is testing

Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Ulm 219
Not applicableUnknownNCT01502176
What this trial is testing

A Retrospective Register Study to Map the Frequency of Short Duration Atrial Fibrillation (AF) Among All Patients Admitted to Roskilde Sygehus in Denmark in 2010

Who this might be right for
Type of Atrial FibrillationMedical HistoryCurrent Treatment+1 more
Zealand University Hospital 1,600
Not applicableStudy completedNCT04757467
What this trial is testing

Comparison of Frequency & Duration of Task Practice During Constraint Induced Movement Therapy

Who this might be right for
Stroke
Riphah International University 96
Not applicableLooking for participantsNCT06194747
What this trial is testing

Improving Status Epilepticus Treatment Times

Who this might be right for
Status Epilepticus
Nationwide Children's Hospital 450
Post-approval studies (Phase 4)Not Yet RecruitingNCT06600776
What this trial is testing

Mealtime or Post-meal Dosing of URLi in Medtronic 780G Hybrid Closed Loop System

Who this might be right for
Type 1 Diabetes (T1D)
Tel-Aviv Sourasky Medical Center 50
Not applicableNot Yet RecruitingNCT07652190
What this trial is testing

Comparison of Day Hospitalization Versus Full-Time Hospitalization in the Treatment of Severe Adolescent Obesity

Who this might be right for
Severe Adolescent ObesityAdolescent ObesityPediatric Obesity
Fondation Santé des Étudiants de France 126
Post-approval studies (Phase 4)Study completedNCT00401726
What this trial is testing

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Who this might be right for
Depressive Disorder, Major
Wyeth is now a wholly owned subsidiary of Pfizer 537
Not applicableEnrolling By InvitationNCT07154238
What this trial is testing

Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.

Who this might be right for
Obesity
Novo Nordisk A/S 2,546
Next Page